학술논문

Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
Document Type
Article
Source
In: Thoracic Cancer. (Thoracic Cancer, March 2024, 15(7):529-537)
Subject
Language
English
ISSN
17597714
17597706